All Issue

2020 Vol.1, Issue 2 Preview Page

Review article

March 2020. pp. 15-20
Abstract
Sorry, not available.
Click the PDF button.
References
1
American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders : DSM-IV, 4th ed. Washington DC, American Psychiatric Association, 1994
2
World Health Organization. International Classification of Diseases and Related Health Problems, 10th ed., Geneva, World Health Organization, 1994
3
Serefoglu EC et al., An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation, J Sex Med, 2014
4
Berkovitch M et al., Efficacy of Prilocaine-lidocaine cream in the treatment of premature ejaculation, J Urol, 1995
10.1097/00005392-199510000-000257658537
5
Atikeler MK et al., Optimum usage of prilocaine-lidocaine cream in premature ejaculation, Andrologia, 2002
10.1046/j.1439-0272.2002.00511.x12472618
6
Busato W et al., Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study, BJU Int, 2004
10.1111/j.1464-410X.2003.04773.x15142155
7
Pu C et al., Topical anesthetic agents for premature ejaculation: A systematic review and meta-analysis, Urology, 2013
10.1016/j.urology.2012.12.02823434101
8
Dinsmore et al., Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation, BJU Int, 2007
10.1111/j.1464-410X.2006.06583.x17129234
9
Dinsmore WW et al., PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: Results of a phase III, multicentre, double-blind, placebo-controlled study, BJU Int, 2009
10.1111/j.1464-410X.2009.08456.x19245438
10
Choi HK et al., Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study, Int J Impot Res, 1999
10.1038/sj.ijir.390043110553804
11
Choi HK et al., Clinical study of SS-cream in patients with lifelong premature ejaculation, Urology, 2000
10.1016/S0090-4295(99)00415-X
12
Martyn-St James M et al., Topical anaesthetics for premature ejaculation: A systematic review and meta- analysis, Sex Health, 2016
10.1071/SH1504226599522
13
Waldinger MD et al., Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta- analysis, Int J Impot Res, 2004
10.1038/sj.ijir.390117214961051
14
Waldinger MD et al., The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment, Psychopharmacology (Berl), 2002
10.1007/s00213-001-0980-311889497
15
Safarinejad MR, Safety and efficacy of escitalopram in the treatment of premature ejaculation: A double blind, placebo-controlled, fixed-dose, randomized study, J Clin Psychopharmacol, 2007
10.1097/jcp.0b013e31814b98d417873675
16
Zhang D et al. Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis, BMC Urol, 2019
10.1186/s12894-018-0431-730606186PMC6318994
17
Waldinger MD et al., On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment, Eur Urol, 2004
10.1016/j.eururo.2004.05.00515363569
18
McMahon CG et al., Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies, J Urol, 1999
10.1097/00005392-199904010-00854
19
Kim SW et al., Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: A randomized, double-blind, placebo- controlled, fixed-dose, parallel-grouped clinical study, Int J Impot Res, 2018
10.1038/s41443-017-0011-529203842
20
Choi JB et al., Efficacy and safety of on demand clomipramine for the treatment of premature ejaculation: A multicenter, randomized, double-blind, phase III clinical trial, J Urol, 2019
10.1016/j.juro.2018.07.08930086277
21
Modi NB et al., Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation, J Clin Pharmacol, 2006
10.1177/009127000528485016490806
22
Giuliano F et al., Effect of acute dapoxetine administration on the pudendal motoneuron reflex in anesthetized rats: Comparison with paroxetine, J Urol, 2007
10.1016/j.juro.2006.08.07917162096
23
Pryor JL et al., Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: An integrated analysis of two double-blind, randomised controlled trials, Lancet, 2006
10.1016/S0140-6736(06)69373-2
24
Du Y et al., Efficacy and safety of "on-demand" dapoxetine in treatment of patients with premature ejaculation: a meta-analysis, Med Sci Monit, 2019
10.12659/MSM.91360631171764PMC6570993
25
Martyn-St James M et al., Tramadol for premature ejaculation: a systematic review and meta-analysis, BMC Urol, 2015
10.1186/1471-2490-15-625636495PMC4417346
26
Eassa BI et al., Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation, Asian J Androl, 2013
10.1038/aja.2012.9623103596PMC3739134
27
Chen J et al., The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: A critical analysis of basic science and clinical data, Eur Urol, 2007
10.1016/j.eururo.2007.08.00517728050
28
Sun Y et al., Efficacy of phosphodiesterase-5 inhibitor in men with premature ejaculation: a new systematic review and meta-analysis, Urology, 2015
10.1016/j.urology.2015.06.05126278825
29
Martyn-St James M et al. Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis, Eur Urol Focus, 2017
10.1016/j.euf.2016.02.00128720356PMC5503121
30
Sadeghi-Jejad H et al., Premature ejaculation: current medical treatment and new directions, J Sex Med, 2008
10.1111/j.1743-6109.2008.00831.x18439148
31
Atan A et al., Comparison of the efficacy of fluoxetine alone vs. fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation, Arch Esp Urol, 2000
32
Mills EJ et al., Demystifying trial networks and network meta-analysis, BMJ, 2013
10.1136/bmj.f291423674332
33
Jian Z et al., Pharmacotherapy of premature ejaculation: a systematic review and network meta-analysis, Int Urol Nephrol, 2018
10.1007/s11255-018-1984-930225547
34
Sridharan K et al., Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials, Int J Impot Res, 2018.
10.1038/s41443-018-0030-x29921893
35
Qin Z, Wang Y, Zhu J et al., Safety and efficacy characteristics of oral drugs in patients with premature ejaculation: a Bayesian network meta-analysis of randomized controlled trials, Int J Impot Res, 2019
10.1038/s41443-019-0146-731024113
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 1
  • No :2
  • Pages :15-20